Quality Chemical Industries Limited (UGSE: QCIL)

Uganda flag Uganda · Delayed Price · Currency is UGX
55.00
0.00 (0.00%)
At close: Oct 25, 2024
-15.38%
Market Cap 200.86B
Revenue (ttm) 265.34B
Net Income (ttm) 31.76B
Shares Out 3.65B
EPS (ttm) 8.70
PE Ratio 6.32
Forward PE n/a
Dividend 5.70 (10.36%)
Ex-Dividend Date Jul 24, 2024
Volume n/a
Open n/a
Previous Close 55.00
Day's Range n/a
52-Week Range 52.00 - 70.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 15, 2024

About QCIL

Quality Chemical Industries Limited, a pharmaceutical manufacturing company, produces treatments for HIV/AIDS, Malaria, Hepatitis, and other products in Uganda. It offers antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics, and antidiabetics products; and Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets for the treatment of HIV infection. The company also offers Lumartem/Lumet tablets for the treatment of malaria; Texavir and Zentair for the treatment of Hepatitis B; and Isoniazid... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 362
Stock Exchange Uganda Securities Exchange
Ticker Symbol QCIL
Full Company Profile

Financial Performance

In 2023, QCIL's revenue was 265.34 billion, an increase of 19.81% compared to the previous year's 221.47 billion. Earnings were 31.76 billion, an increase of 67.28%.

Financial Statements

News

There is no news available yet.